148 related articles for article (PubMed ID: 8665882)
1. The effect of reversal of myoneural blockade on cerebrospinal fluid pressure following cerebral aneurysm surgery.
Fawcett WJ; Chung RA; Fairley CJ; Hollway TE
Eur J Anaesthesiol; 1995 Nov; 12(6):591-5. PubMed ID: 8665882
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
3. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
4. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
[TBL] [Abstract][Full Text] [Related]
5. Reversal of vecuronium with neostigmine: a comparison between male and female patients.
Saitoh Y; Aoki K; Okazaki M; Hirama T; Isosu T; Murakawa M
Fukushima J Med Sci; 2009 Dec; 55(2):61-70. PubMed ID: 20608096
[TBL] [Abstract][Full Text] [Related]
6. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Hayes A; Breslin D; Reid J; Mirakhur RK
Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
[TBL] [Abstract][Full Text] [Related]
7. Delayed reversal of a potentiated rocuronium neuromuscular block.
Dubois PE
Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
[No Abstract] [Full Text] [Related]
8. Reversal of vecuronium with neostigmine in patients with diabetes mellitus.
Saitoh Y; Hattori H; Sanbe N; Nakajima H; Akatu M; Murakawa M
Anaesthesia; 2004 Aug; 59(8):750-4. PubMed ID: 15270964
[TBL] [Abstract][Full Text] [Related]
9. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
Lien CA
Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
[No Abstract] [Full Text] [Related]
10. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
[No Abstract] [Full Text] [Related]
11. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
12. [Investigations into neostigmine-induced inhibition of neuromuscular transmission].
Kitajima O; Suzuki T; Fukano N; Miyake E; Saeki S; Ogawa S
Masui; 2009 Apr; 58(4):410-5. PubMed ID: 19363999
[TBL] [Abstract][Full Text] [Related]
13. Recovery characteristics following antagonism of vecuronium with edrophonium, neostigmine or pyridostigmine.
Yungbluth J; Henry JD; McAnallen K; Albee DT
AANA J; 1988 Apr; 56(2):127-33. PubMed ID: 2897148
[No Abstract] [Full Text] [Related]
14. Effects of pipecuronium and pancuronium on cerebrospinal fluid pressure in neurosurgical patients.
Thiel A; Wyderka T; Wagner RM; Ebel H; Hempelmann G
Acta Anaesthesiol Belg; 1996; 47(2):59-65. PubMed ID: 8869672
[TBL] [Abstract][Full Text] [Related]
15. [Myoneural conduction blockade by choline esters in the presence of cholinesterase inhibitors and restoration of conduction by cholinesterase reactivators].
Protas LL
Dokl Akad Nauk SSSR; 1973 Apr; 209(5):1243-6. PubMed ID: 4350639
[No Abstract] [Full Text] [Related]
16. Preclinical pharmacology of sugammadex.
Bom A; Hope F; Rutherford S; Thomson K
J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to upper airway obstruction during partial neuromuscular block.
D'Honneur G; Lofaso F; Drummond GB; Rimaniol JM; Aubineau JV; Harf A; Duvaldestin P
Anesthesiology; 1998 Feb; 88(2):371-8. PubMed ID: 9477058
[TBL] [Abstract][Full Text] [Related]
19. Emergency use of sugammadex after failure of standard reversal drugs.
Lenz A; Hill G; White PF
Anesth Analg; 2007 Mar; 104(3):585-6. PubMed ID: 17312213
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Lee C; Katz RL
J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
